𝔖 Bobbio Scriptorium
✦   LIBER   ✦

First missense mutation in the SOST gene causing sclerosteosis by loss of sclerostin function

✍ Scribed by Elke Piters; Cavit Culha; Martiene Moester; Rutger Van Bezooijen; Dirk Adriaensen; Thomas Mueller; Stella Weidauer; Karen Jennes; Fenna de Freitas; Clemens Löwik; Jean-Pierre Timmermans; Wim Van Hul; Socrates Papapoulos

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
520 KB
Volume
31
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis

Sclerosteosis is a rare bone dysplasia characterized by greatly increased bone mass, especially of the long bones and the skull. Patients are tall, show facial asymmetry and often have syndactyly. Clinical complications are due to entrapment of cranial nerves. The disease is thought to be due to loss-of-function mutations in the SOST gene. The SOST gene product, sclerostin, is secreted by osteocytes and transported to the bone surface where it inhibits osteoblastic bone formation by antagonizing Wnt signaling. In a small Turkish family with sclerosteosis, we identified a missense mutation (c.499T>C; p.Cys167Arg) in exon 2 of the SOST gene. This type of mutation has not been previously reported and using different functional approaches, we show that it has a devastating effect on the biological function of sclerostin. The affected cysteine is the last cysteine residue of the cystine-knot motif and loss of this residue leads to retention of the mutant protein in the ER, possibly as a consequence of impaired folding. Together with a significant reduced ability to bind to LRP5 and inhibit Wnt signaling, the p.Cys167Arg mutation leads to a complete loss of function of sclerostin and thus to the characteristic sclerosteosis phenotype. ©2010

📜 SIMILAR VOLUMES

Two distinct phenotypes caused by two di
Two distinct phenotypes caused by two different missense mutations in the same codon of the VHL gene
✍ Bradley, John F.; Collins, Debra L.; Schimke, R. Neil; Parrott, Heather N.; Roth 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 22 KB 👁 1 views

We have identified a family segregating von Hippel-Lindau (VHL) disease with a previously unreported T547A mutation in exon 1 of the VHL gene that causes a Tyr112 to Asn missense alteration in the protein. The mutation was identified by nucleotide sequencing and confirmed by restriction enzyme diges

Exon 6 skipping in the fanconi anemia C
Exon 6 skipping in the fanconi anemia C gene associated with a nonsense/missense mutation (775C→T) in exon 5: The first example of a nonsense mutation in one exon causing skipping of another downstream
✍ Jerome R. Lo Ten Foe; Frank A.E. Kruyt; Marjolein B.M. Zweekhorst; Gerard Pals; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB 👁 1 views

## How Fancbni anemia (FA) is a rare autosomal recessive disease characterized by diverse clinical symptoms, chromosomal instability, and hypersensitivity

Glycogen storage disease type IIIa: firs
Glycogen storage disease type IIIa: first report of a causative missense mutation (G1448R) of the glycogen debranching enzyme gene found in a homozygous patient
✍ Minoru Okubo; Fumio Kanda; Asako Horinishi; Keiichi Takahashi; Shiho Okuda; Kazu 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 1 views

Several different mutations in the glycogen-debranching enzyme gene AGL have been found in patients with glycogen storage disease type III (GSD III) to date, but no missense mutations have been reported for GSD III, only nonsense, splicing, and deletion/insertion lesions. Here we describe a novel G1